Ion channels: gated pores
An ion channel is a protein with a pore through the membrane that lets charged atoms — sodium, potassium, calcium — rush in or out when a gate opens. These rushing ions create the electrical signals of nerves and the beat of the heart, so channels are powerful targets where timing and electricity matter. A drug can plug the pore or hold the gate, dialling the flow down. The calcium channel blocker, which relaxes blood vessels and steadies the heart by limiting calcium entry, is a everyday example.
Transporters: molecular pumps
A transporter is a protein that carries specific molecules across a membrane — picking up a passenger on one side, changing shape, and releasing it on the other. Block a transporter and the cargo piles up where you want it. The famous SSRI antidepressants do exactly this: they block the transporter that clears serotonin out of the gap between nerve cells, so serotonin lingers and its signal strengthens. Transporters are a reminder that you don't always have to change a signal directly — sometimes you change how fast a molecule is cleared away.
Inside the nucleus, and the RNA frontier
Some targets live deep inside the cell. A nuclear receptor is a receptor that, once bound by a steroid or similar small molecule, travels into the nucleus and acts as a transcription factor — switching genes on or off. Steroid medicines work this way, reaching all the way to the genome. These targets are powerful but broad, so selectivity is a constant concern.
The newest frontier skips proteins entirely and targets the genetic message. An oligonucleotide therapeutic is a short, designed strand of nucleic acid that recognises a matching RNA sequence by base-pairing. An antisense oligonucleotide binds a target messenger RNA and marks it for destruction or alters how it is read; an siRNA recruits the cell's own machinery to chop up that RNA. Because they are programmed by sequence rather than by 3D pocket shape, these drugs can reach targets that classic small molecules cannot.